Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.
Emerg Infect Dis
; 27(3): 985-987, 2021 03.
Article
em En
| MEDLINE
| ID: mdl-33622487
ABSTRACT
We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Preparações Farmacêuticas
/
Tuberculose Resistente a Múltiplos Medicamentos
/
Mycobacterium tuberculosis
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Emerg Infect Dis
Assunto da revista:
DOENCAS TRANSMISSIVEIS
Ano de publicação:
2021
Tipo de documento:
Article